James S Kuo insider trades: Adeona Pharmaceuticals (AEN) stock purchases
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where James reports to the SEC
Open-market buys and sales
5 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Aug 30, 2011 | AEN | ↑ Buy | 4,500 | $0.69 | $3K | Direct | Aug 31, 2011 (1d) |
| Sep 3, 2008 | DSKA | ↑ Buy | 1,000 | $0.31 | $310 | Direct | Sep 4, 2008 (1d) |
| Aug 27, 2008 | DSKA | ↑ Buy | 2,000 | $0.30 | $600 | Direct | Aug 28, 2008 (1d) |
| Aug 25, 2008 | DSKA | ↑ Buy | 900 | $0.20 | $180 | Direct | Aug 28, 2008 (3d) |
| Dec 6, 2007 | DSKA | ↑ Buy | 1,000 | $0.55 | $550 | Direct | Dec 7, 2007 (1d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
About James S Kuo's insider trades
James S Kuo is Chairman, CEO & President at Adeona Pharmaceuticals (AEN). Since Dec 6, 2007, James has reported 5 open-market purchases worth $5K and no sales on SEC Form 4. There have been no open-market trades in the last 12 months.
Their filings also include grants and awards (8 filings), shares returned to the company (1 filing). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every AEN insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.